Unmet needs for treatment of alcohol and drug use in four cities in Mexico

Salud Mental

Volumn 32, Issue 4, 2009, Pages 327-333

  Borges, Guilherme ^a   Medina Mora, María Elena ^a   Orozco, Ricardo ^b   Fleiz, Clara ^a   Villatoro, Jorge ^a   Rojas, Estela ^a   Zemore, Sarah ^c  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c ALCOHOL RESEARCH GROUP   (United States)

Author keywords

Alcohol; Border; Drug use; Health services

Indexed keywords

EID: 77952222145     PISSN: 01853325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998;23:893-907.
2. Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J et al. Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry 2008;192:368-75.
3. WHO. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291:2581-90.
4. Rehm J, Monteiro M. Alcohol consumption and burden of disease in the Americas: implications for alcohol policy. Rev Panam Salud Publica 2005;18:241-8.
5. González-Pier E, Gutiérrez-Delgado C, Stevens G, Barraza-Lloréns M, Porras-Condey R et al. Priority setting for health interventions in Mexico's System of Social Protection in Health. Lancet 2006;368:1608-18.
6. Medina-Mora ME, Borges G, Fleiz C, Benjet C, Rojas E et al. Prevalence and correaltes of drug use disorders in Mexico. Rev Panam Salud Publica 2006;19:265-276.
7. Bucardo J, Brouwer KC, Magis-Rodríguez C, Ramos R, Fraga M et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood-borne infections. Drug Alcohol Depend 2005;79:281-293.
8. Berenzon SG, Medina-Mora ME, Lara MA. Mental health services: twenty-five years of research. Salud Mental 2003;26:61-72.
9. Borges G, Medina-Mora ME, Wang PS, Lara C, Berglund P et al. Treatment and adequacy of treatment of mental disorders among respondents to the Mexico National Comorbidity Survey. Am J Psychiatry 2006;163:1371-8.
10. Medina-Mora ME. Encuesta de Consumo de Alcohol, Tabaco y Drogas, 2005. Ciudad Juárez, Monterrey, Tijuana y Querétaro. México: Secretaría de Salud and Instituto Nacional de Psiquiatría; 2005; p.1-62.
11. Medina-Mora ME, Borges G, Villatoro J. The measurement of drinking patterns and consequences in Mexico. J Subst Abuse 2000;12:183-96.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: Fourth Edition; American Psychiatric Association; 1994.
13. World Health Organization. Composite International Diagnostic Interview (version authorize core version 1.1). Geneva, Switzerland; 1993.
14. Caetano R, Tam TW. Prevalence and correlates of DSM-IV and ICD-10 alcohol dependence: 1990 U.S. National Alcohol Survey. Alcohol Alcohol 1995;30:177-186.
15. Caetano R, Room R. Alcohol dependence in the 1990 U.S. National Alcohol Survey: Operationalizing and comparing two nosological systems. Drug Alcohol Review 1994;13:257-267.
16. Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997;27:93-105.
17. Lara C, Medina-Mora ME, Borges G, Zambrano J. Social costs of mental disorders: Disability and work days lost. Salud Mental 2007;30:4-11.
18. Research Triangle Institute. SUDAAN: Professional Software for Survey Data Analysis [computer program] 8.0.1. (ed.) Research Triangle Park, NC, USA: Research Triangle Institute; 2002.
19. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 2000.
20. Medina-Mora ME, Natera G, Borges G. Alcoholismo y abuso de bebidas alcohólicas, in Observatorio mexicano en tabaco, alcohol y otras drogas. México: CONADIC, Secretaría de Salud; 2002; p15-25.
21. Medina-Mora ME, Cravioto P, Ortiz A, Kuri P, Villatoro J. Mexico: systems for the epidemiological diagnosis of drug abuse. Bull Narc 2003;55:105-109.
22. Medina-Mora ME, Guiot ER. Demand of drugs: Mexico in the international perspective. Salud Mental 2003;26:1-11.
23. Hendricks T. On the border. Part 3. Nogales, Sonora: Hospitals in southern Arizona hope to reduce their cost of caring for uninsured immigrants by improving hospitals across the border. San Francisco: Chronicle, vol 1, December 2005; p. A-1.
24. Borges G, Benjet C, Medina-Mora ME, Orozco-Zavala R, Wang P. Treatment of mental disorders for adolescents in Mexico City. J Bulletin World Health Organization 2008;86:757-764.
25. Spence R, Wallisch L, Smith S. Treatment seeking in populations in urban and rural settings on the border. Alcohol Clin Exp Res 2007;31:1002-11.
26. Kessler RC, Berglund P, Demler O, Jin R, Koretz D et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
27. Zemore S, Mulia N, Yu Ye, Borges G, Greenfield TK. Gender, acculturation, and other barriers to alcohol treatment utilization among latinos in three National Alcohol Surveys. J Substance Abuse Treatment 2009 (in press).
28. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J et al. Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. Psychol Med 2005;35:1773-83.
29. Spence RT, Wallisch LS. Alcohol and drug use in rural colonias and adjacent urban areas of the Texas border. J Rural Health 2007;23(Suppl): 55-60.
30. NIDA Principles of drug abuse treatment: A research based guide. Rockville, MD: National Institute of Drug Abuse; 1999; p.54.